Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

E-ISSN： 2213-4778|2|2|60-68

ISSN： 2213-476x

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.2, Iss.2, 2015-12, pp. : 60-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory Aspects of Post-Approval Safety Reporting for Generic Drug Products in the US

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 3, Iss. 3, 2016-12 ,pp. : 142-150

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

By Snodin David J.

BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 25-52

Adis International

Access to resources Recommend Favorite

Developing Therapeutic Immunoglobulins: European Regulatory Perspectives and Implications

By Kurz Manfred

BioDrugs, Vol. 22, Iss. 3, 2008-01 ,pp. : 145-160

Adis International

Access to resources Recommend Favorite

Listening to Patients Changes Clinicians' Perspectives and Improves Care

By Vidal Kathleen

Creative Nursing, Vol. 20, Iss. 2, 2014-05 ,pp. : 122-126

Springer Publishing Company

Access to resources Recommend Favorite

Post-migration Changes in Gender Relations Among Ethiopian Couples Living in Canada

By Hyman Ilene Guruge Sepali Mason Robin Gould Judy Stuckless Noreen Tang Taryn Teffera Hiwot Mekonnen Girma

CJNR (Canadian Journal of Nursing Research), Vol. 36, Iss. 4, 2004-12 ,pp. : 74-89

McGill School of Nursing

Access to resources Recommend Favorite